WHO "Vaccine Supply to Low-Income Countries to Begin as Early as This Month"

Supply of 2 Billion Vaccine Doses Through COVAX Facility
"Currently Raised $6 Billion of $7 Billion Target"

On the 7th (local time), the World Health Organization (WHO) announced that support for COVID-19 vaccines for low-income countries will begin between late January and mid-February. Photo by World Health Organization website direct capture

[Asia Economy Reporter Ryu Tae-min] The World Health Organization (WHO) announced on the 7th (local time) that it will begin providing COVID-19 vaccine support to low-income countries as early as the end of this month.

According to major foreign media on the day, Kate O'Brien, WHO's Immunization Director, stated at a WHO social media (SNS) event, "The COVAX facility can deliver more than 2 billion doses of vaccines," adding, "Distribution is scheduled to begin between late January and mid-February."

The COVAX facility is an international project organization for the joint purchase and distribution of COVID-19 vaccines, jointly operated by the World Health Organization (WHO), GAVI, the Vaccine Alliance, and the Coalition for Epidemic Preparedness Innovations (CEPI). This organization aims to supply vaccines to 20% of the global population, focusing on low-income countries, by the end of this year.

O'Brien added, "Approximately 7 billion USD (7.64 trillion KRW) is needed to supply sufficient vaccines by the end of this year," and "COVAX has already raised about 6 billion USD (6.55 trillion KRW) of that amount."

On the 31st of last month, WHO approved the emergency use of the COVID-19 vaccine jointly developed by Pfizer and BioNTech to support vaccine distribution worldwide, including developing countries. Additionally, WHO is reportedly reviewing the emergency use of vaccines from AstraZeneca and Sinovac.

This content was produced with the assistance of AI translation services.